1.Roles of the cross talk between MAP kinases and Keap1-Nrf2-ARE signaling pathways in chronic obstructive pulmonary disease.
Shu-Jun WANG ; Ya-Jun CHEN ; Shan-Shan WANG ; Dian-Lei WANG ; Chen-Yin WANG ; Li-Li YANG ; Jin-Pei CHEN
Acta Pharmaceutica Sinica 2015;50(2):133-140
Chronic obstructive pulmonary disease (COPD), a common preventable and treatable disease, is characterized by airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways. Its main pathological manifestations include airway inflammation, mucus hypersecretion, oxidative stress and apoptotic epithelial cells. Recent research suggests that MAP kinases and Keap1-Nrf2-ARE signaling pathway are involved in the pathological process of inflammation and oxidative stress. This review explores the potential role of the cross talk of these signaling pathways in airway inflammation, mucus hypersecretion, oxidative stress and apoptotic epithelial cells. To clarify the roles of cross talk between MAP kinases and Keap1-Nrf2-ARE signaling pathway, we also focus on the drugs related to that in the treatment of COPD, and it provides ideas for more drug research in the treatment of COPD.
Apoptosis
;
Epithelial Cells
;
cytology
;
Humans
;
Inflammation
;
Intracellular Signaling Peptides and Proteins
;
Kelch-Like ECH-Associated Protein 1
;
Mitogen-Activated Protein Kinases
;
NF-E2-Related Factor 2
;
Oxidative Stress
;
Pulmonary Disease, Chronic Obstructive
;
metabolism
;
Respiratory System
;
Signal Transduction
2.Pregnancy outcome among patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
Qian JIANG ; Bin JIANG ; Shan-shan CHEN ; Hao JIANG ; Ya-zhen QIN ; Yue-yun LAI ; Hong-xia SHI ; Xiao-jun HUANG
Chinese Journal of Hematology 2012;33(1):6-9
OBJECTIVETo observe the pregnancy outcome among patients with chronic myelogenous leukemia (CML) treated with tyrosine kinase inhibitors (TKIs).
METHODSData associated with pregnancy, delivery and neonate from the patients or patient's spouse who conceived while receiving TKIs were collected retrospectively.
RESULTSTwo young female patients (who had been on imatinib therapy for 90 and 91 months, respectively) and spouses of 10 male patients (involving 7 patients who had received imatinib for a median of 60 months and 3 who had received dasatinib for 2.5 months to 7 months, respectively) with median age of 33.5 years (range 26 - 46 years) conceived and gave birth to 12 babies. One woman took imatinib throughout her pregnancy except one month. The other one took imatinib throughout her pregnancy and had breast-fed while on imatinib therapy for nearly half a year postpartum. Among the 12 babies, one was born prematurely with low birth weight and hypospadias (surgical repair after birth), the others were all healthy with no congenital defects. The median age of the children at the date of this report is 17.5 months (range 3 to 101 months), and they all have a normal pattern of growth and development.
CONCLUSIONSConception among patients with CML while receiving TKIs may result in normal pregnancies. The possible effects of TKIs on birth abnormalities cannot be ruled out. It is recommended that childbearing female patients should be advised to practice adequate methods of contraception and should not breast-feed while on TKIs therapy. In cases of accidental pregnancy, risk/benefit evaluations must be carried out carefully on an individual basis. No special precautions apply for male patients being treated with imatinib.
Adult ; Antineoplastic Agents ; therapeutic use ; Benzamides ; Dasatinib ; Female ; Humans ; Imatinib Mesylate ; Infant ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive ; drug therapy ; Male ; Middle Aged ; Piperazines ; therapeutic use ; Pregnancy ; Pregnancy Outcome ; Protein Kinase Inhibitors ; therapeutic use ; Protein-Tyrosine Kinases ; antagonists & inhibitors ; Pyrimidines ; therapeutic use ; Retrospective Studies ; Thiazoles ; therapeutic use ; Treatment Outcome
3.Impact of priming on seed germination and seedling growth of Oldenlandia diffusa under drought stress.
Zai-Biao ZHU ; Wei-Wei LU ; Qiao-Sheng GUO ; Ya-Yue CAO ; Shan FENG ; Zi-Jun NING
China Journal of Chinese Materia Medica 2014;39(8):1391-1395
Current study was carried out to optimize the priming condition of Oldenlandia diffusa seeds, and improve germination rate and seed vigor of 0. diffusa seeds under drought conditions. Uniform design was used to optimize the concentration and priming time of three priming materials (PEG, KNO3, GA3). Different concentrations of polyethylene glycol (PEG) was used to simulate drought stress. The seedling was cultured in 1/4 Hoagland medium for 30 d. The results showed that seed priming treatment with 366 mg x kg(-1) GA3 for 1h resulted in significant increase in germination rate, germination index, vigor, root length, plant height and biomass of O. diffusa seeds under drought stress (15% PEG), while seed priming with 3.0% KNO3 for 1 h showed little effect on germination and growth of O. diffusa seeds under drought stress. Seed priming treatment with appropriate GA3 concentration and priming time could enhance seed germination and drought resistance of O. diffusa in seedling stage.
Droughts
;
Germination
;
Oldenlandia
;
growth & development
;
physiology
;
Seedlings
;
growth & development
;
physiology
;
Seeds
;
growth & development
;
physiology
;
Stress, Physiological
4.Experimental study on aging effect of Angelica sinensis polysaccharides combined with cytarabine on human leukemia KG1alpha cell lines.
Chun-Yan XU ; Shan GENG ; Jun LIU ; Jia-Hong ZHU ; Xian-Ping ZHANG ; Rong JIANG ; Ya-Ping WANG
China Journal of Chinese Materia Medica 2014;39(7):1260-1264
The latest findings of our laboratory showed that Angelica sinensis polysaccharide (ASP) showed a definite effect in regulating the aging of hematopoietic stem cells. Leukemia is a type of malignant hematopoietic tumor in hematopoietic stem cells. There have been no relevant reports about ASP's effect in regulating the aging of leukemia cells. In this study, human acute myeloid leukemia (AML) KG1alpha cell lines in logarithmic growth phase were taken as the study object, and were divided into the ASP group, the cytarabine (Ara-C) group, the ASP + Ara-C group and the control group. The groups were respectively treated with different concentration of ASP, Ara-C and ASP + Ara-C for different periods, with the aim to study the effect of ASP combined with Ara-C in regulating the aging of human acute myeloid leukemia KG1alpha cell lines and its relevant mechanism. The results showed that ASP, Ara-C and ASP + Ara-C could obviously inhibit KG1alpha cell proliferation in vitro, block the cells in G0/G1 phase. The cells showed the aging morphological feature. The percentage of positive stained aging cells was dramatically increased, and could significantly up-regulate the expression of aging-related proteins P16 and RB, which were more obvious in the ASP + Ara-C group. In conclusion, the aging mechanism of KG1alpha cell induced by ASP and Ara-C may be related to the regulation of the expression of aging-related proteins, suggesting that the combined administration of ASP and anticancer drugs plays a better role in the treatment of leukemia .
Aging
;
drug effects
;
genetics
;
metabolism
;
Angelica sinensis
;
chemistry
;
Cell Cycle
;
drug effects
;
Cell Proliferation
;
drug effects
;
Cyclin-Dependent Kinase Inhibitor p16
;
genetics
;
metabolism
;
Humans
;
Leukemia
;
drug therapy
;
genetics
;
metabolism
;
physiopathology
;
Polysaccharides
;
pharmacology
;
Retinoblastoma Protein
;
genetics
;
metabolism
;
Tumor Cells, Cultured
5.Relationship of immunophenotypic features with minimal residual disease detection and gene types in 221 cases of acute promyelocytic leukemia.
Ya-Zhe WANG ; Ya-Zhen QIN ; Bin JIANG ; Hong-Hu ZHU ; Yan CHANG ; Le HAO ; Jin-Lan LI ; Ling-Di LI ; Shan-Shan CHEN ; Xiao-Jun HUANG ; Yan-Rong LIU
Journal of Experimental Hematology 2009;17(2):271-276
This study was aimed to investigate the relationship of immunophenotypic features with minimal residual disease (MRD) detection and gene types in APL patients. Immunophenotypes were analyzed in 221 newly diagnosed APL patients by using four-color flow cytometry. Among of them, CD123 antibody was examined in 87 patients and the fused gene pml-raralpha were detected by PCR in 196 specimens simultaneously. The results of immunophenotyping demonstrated that the positive percentages of CD123, CD33 and CD9 in newly diagnosed APL patients were 100%, 99.1% and 96.0% respectively, and mean percentages of positive cells in positive patients were all around 90%. Although the positive rates of CD117, CD13, CD38 and CD64 were all above 96%, but the mean percentages of positive cells in different positive patients were diverse and average percentages of positive cells were about 70%. CD15, CD56 and CD11b were expressed in some patients, but CD34 and HLA-DR were rarely expressed in the majority of patients, and average positive percentages were all lower. Among 196 newly diagnosed APL patients, bcr1, bcr2 and bcr3 expressions were 63.3%, 4.6% and 32.1% respectively. The results showed a strong correlation of positive expression of CD34 with bcr3 isoform. When cut-off value was chosen as 20%, the proportions of CD34 positive patients in bcr3 and bcr1 cases were 15.4% (10/65) and 3.3% (4/121) separately, which had a significant difference (p < 0.05). When cut-off value was 10%, bcr3 cases had a significantly higher percentage of CD34 positive, compared with bcr1 cases (p < 0.001), which was 47.7% (31/65) and 5.8% (7/121) respectively. However, there was no statistically significant difference on the other antigens between the two groups. Bcr3 isoform was highly indicated when CD34 was positive and non- large side scatter (NL-SSC) was shown in APL cells. It is concluded that there is a unique characteristics of immunophenotyping, and antigens such as CD123, CD33 and CD9 are more applicable to the detection of MRD in APL patients. The positive expression of CD34 and NL-SSC are associated with bcr3 isoform, and the relationship between gene type and antigen expression can be suggested more accurately when the cut-off value is chosen as 10%.
Adolescent
;
Adult
;
Aged
;
Antigens, CD
;
genetics
;
Child
;
Female
;
Flow Cytometry
;
Humans
;
Immunophenotyping
;
Leukemia, Promyelocytic, Acute
;
diagnosis
;
genetics
;
immunology
;
Male
;
Middle Aged
;
Neoplasm, Residual
;
diagnosis
;
genetics
;
Young Adult
6.Risk factors of the failure in digit replantation.
Fei YIN ; Jing-yi MI ; Yong-jun RUI ; Ya-jun XU ; Qun YAO ; Yang QIU ; Zun-shan KE ; Zhen-zhong SUN
China Journal of Orthopaedics and Traumatology 2015;28(5):429-432
OBJECTIVETo explore the relative factors on the failure in digit replantation in order to take preventions to control the risk factors.
METHODSFrom January 2013 to December 2013, 236 consecutive patients (311 fingers) underwent digit replantation were collected to analyze retrospectively, involving 183 males and 53 females with an average age of 34.5 years old ranging from 2 to 62 years old (6 cases under 6 years old and 230 cases elder than 6 years old). There were 51 thumbs, 87 index fingers, 78 middle fingers, 63 ring fings and 32 little thumbs. Forty cases(forty fings) who were failured as the observation group, the others as the control group. The factors of age, gender, finger, cause of injury, smoking history, ischemia duration, plane of division, condition of venous drainage and condition of arterial repair we assessed.
RESULTSAll 236 cases with 311 fingers were replanted, 40 fingers were failured after operation. The relative factors on the failure in digit replantation included smoking history, cause of injury, plane of division, condition of venous drainage and condition of arterial repair (P< 0.05). There were no significant correlation between the failure and age, gender, finger and ischemia duration (P>0.05).
CONCLUSIONSmoking history, causes of injury, plane of division, condition of venous drainage and condition of arterial repair are risks of failure in digit replantation. Before choosing the type of operation, it should be think about the patient's general conditions, injury status, grasp firmly the operative indications and actively carry out surgical treatment.
Adolescent ; Adult ; Child ; Female ; Finger Injuries ; surgery ; Fingers ; surgery ; Humans ; Male ; Middle Aged ; Reconstructive Surgical Procedures ; Replantation ; Retrospective Studies ; Risk Factors ; Thumb ; injuries ; surgery ; Treatment Failure ; Young Adult
7.Epitope Tagging of the rpoS gene of Y. pestis by Recombineering Technique
Jian-Shan ZHANG ; Ze-Liang CHEN ; Ya-Jun SONG ; Zhao-Biao GUO ; Jin WANG ; Hong-Xia WANG ; Jun-Hui ZHAI ; Rui-Fu YANG ;
China Biotechnology 2006;0(05):-
Objective: To facilitate the functional analysis of chromosomal genes and their products, the recombineering technique to epitope tagging of chromosomal genes of Y. pestis was adapted. Methods: The epitope tag was generated by primer annealing and then fused with resistance gene by fusion PCR. The epitope-resistance cassette was inserted into pBluecript, resulted in the template plasmid, pBS-MH. The tagging cassette for rpoS was obtained by PCR amplification from pBS-MH with primers containing homology specific to the target gene. PCR products were transformed into recombination competent cells and recombinants were selected. PCR and DNA sequencing were used to confirm the correct tagging event. The expression of the tagged protein was detected with Western blot by using monoclonal antibody to the epitope. Results: The template plasmid containing fusion of epitope and resistance gene was successfully constructed. The sigma factor gene, rpoS, was tagged with a myc-his tag at the COOH terminus. Expression of the tagged rpoS was successfully detected indirectly by the antibody against His tag. Conclusion: The chromosomal gene tagging by recombineering technique represents a powerful tool in the functional study of bacterial genes and their products.
8.Clinical treatment of small hepatocellular carcinoma.
Rong-Ping GUO ; Min-Shan CHEN ; Xiao-Jun LIN ; Ya-Qi ZHANG ; Jin-Qing LI
Acta Academiae Medicinae Sinicae 2006;28(3):318-321
OBJECTIVETo evaluate the suitable treatment methods of small hepatocellular carcinoma (SHCC).
METHODSFrom 2000 to 2004, 849 cases of SHCC (< or = c5 cm) were enrolled and divided into two groups: resection group (n = 406) and minimally invasive treatment (MIT) group (n = 443). The survival rates, recurrence rates, and post-treatment complications were compared retrospectively.
RESULTSThe 3-year survival rate in the resection group was 72.1%. The 3-year survival rates in tumor < or = 3 cm and tumor 3-5 cm of resection group were 73.3% and 70.5% (P = 0.46), respectively. The 1-year, 2-year, and 3-year recurrence rates in resection group were 13.5%, 29.9%, and 39.8%, respectively. The 3-year survival rates in MIT group was 73.8%. The 3-year survival rates in tumor < or = 3 cm and tumor 3-5 cm of MIT group were 74.7% and 72.2% (P = 0.45), respectively. The 1-year, 2-year, and 3-year recurrence rates in MIT group were 12.6%, 28.7%, and 40.4%, respectively. The 3-year survival rate was significantly different between these two group in tumor < or = 3 cm (P < 0.05). The post-treatment complication rates of these two group were 30.8% and 6.1% (P < 0.01), respectively.
CONCLUSIONSMIT is as effective as the traditional resection in SHCC. However, MIT is superior to the traditional resection in terms of minimal invasion and less post treatment complication rate. The recurrence rate of HCC was still high after treatment. Comprehensive therapies, including MIT, may increase the survival rate and life quality in SHCC patients.
Adult ; Aged ; Carcinoma, Hepatocellular ; surgery ; Female ; Hepatectomy ; Humans ; Liver Neoplasms ; surgery ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; prevention & control ; Retrospective Studies ; Survival Rate
9.Effect of high power microwave radiation on ultrastructure of neuron synapse and content of amino acid neurotransmitters in hippocampus of rats.
Li WEI ; Rui-yun PENG ; Li-feng WANG ; Ya-bing GAO ; Shui-ming WANG ; Jun-jie MA ; De-wen WANG ; Ping QIU ; Tian-hao XU ; Guo-shan YANG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2006;24(4):245-247
10.Effect of blocking transforming growth factor beta signalling on culture-activated rat hepatic stellate cells.
Ya-jun ZHOU ; Dong-mei YIN ; Hong-shan CHEN ; Hui-xia ZHU ; Xin WANG
Chinese Journal of Hepatology 2003;11(5):282-284
OBJECTIVETo study the effects of blocking transforming growth factor beta (TGF-beta) signalling on culture-activated rat hepatic stellate cells (HSCs).
METHODSAfter cultured in plastic dish for two days, HSCs were infected with adenovirus vector AdT beta-ExR or AdLacZ (control) at 10 multiplicity of infection (MOI) and incubated for four days. The expression of type I collagen, alpha-smooth muscle actin (alpha-SMA) and the proliferation of HSCs were analyzed by ELISA, western blot, immunocytochemistry and BrdU uptake respectively.
RESULTSThe expression level of type I collagen in HSCs infected with AdT beta-ExR was 42.99% of that in HSCs infected with AdLacZ (q = 9.100, P < 0.001). The expression of alpha-SMA in HSCs infected with AdTbeta-ExR was also inhibited evidently. But the BrdU uptake in HSCs infected with AdLacZ was 49.24% of that in HSCs infected with AdTbeta-ExR (q = 7.835, P < 0.001).
CONCLUSIONSThe blockade of TGF-beta signalling in cultured rat HSCs can inhibit their activation significantly, but promote their proliferation.
Adenoviridae ; genetics ; Animals ; Cell Division ; drug effects ; Cells, Cultured ; Collagen Type I ; biosynthesis ; genetics ; Gene Transfer Techniques ; Genetic Vectors ; Liver ; drug effects ; pathology ; physiology ; Liver Cirrhosis ; pathology ; Rats ; Rats, Sprague-Dawley ; Signal Transduction ; Transforming Growth Factor beta ; pharmacology